2,351
Views
34
CrossRef citations to date
0
Altmetric
Extra Views

Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model

, , , , , , , , , & show all

References

  • Jitariu AA, Cimpean AM, Ribatti D, et al. Triple negative breast cancer: the kiss of death. Oncotarget. 2017 Jul 11;8(28):46652–46662. PubMed PMID: 28445140; PubMed Central PMCID: PMCPMC5542300.
  • Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008 Mar 10;26(8):1275–1281. PubMed PMID: 18250347.
  • Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014 Jul 12;384(9938):164–172. PubMed PMID: 24529560.
  • Vyas D, Laput G, Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther. 2014;7:1015–1023. PubMed PMID: 24959088; PubMed Central PMCID: PMCPMC4061164.
  • Torres MA, Pace TW, Liu T, et al. Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B. Cancer. 2013 Jun 01;119(11):1951–1959. PubMed PMID: 23512358; PubMed Central PMCID: PMCPMC3663885.
  • De Lorenzo MS, Baljinnyam E, Vatner DE, et al. Caloric restriction reduces growth of mammary tumors and metastases [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Carcinogenesis. 2011 Sep;32(9):1381–1387. PubMed PMID: 21665891; PubMed Central PMCID: PMC3165123. eng.
  • Hursting SD, Lavigne JA, Berrigan D, et al. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans [Review]. Annu Rev Med. 2003;54:131–152. PubMed PMID: 12525670; eng.
  • Saleh AD, Simone BA, Palazzo J, et al. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle. 2013 May 21;12(12). PubMed PMID: 23708519; Eng. DOI:https://doi.org/10.4161/cc.25016
  • Simone BA, Dan T, Palagani A, et al. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer. Cell Cycle. 2016 Sep;15(17):2265–2274. PubMed PMID: 27027731; PubMed Central PMCID: PMCPMC5004690.
  • Lee C, Raffaghello L, Brandhorst S, et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012 Mar 07;4(124):124ra27. PubMed PMID: 22323820; PubMed Central PMCID: PMCPMC3608686.
  • Safdie F, Brandhorst S, Wei M, et al. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One. 2012;7(9):e44603. PubMed PMID: 22984531; PubMed Central PMCID: PMCPMC3439413.
  • Imayama I, Ulrich CM, Alfano CM, et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res. 2012 May 01;72(9):2314–2326. PubMed PMID: 22549948; PubMed Central PMCID: PMCPMC3342840.
  • Xydakis AM, Case CC, Jones PH, et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab. 2004 Jun;89(6):2697–2703. PubMed PMID: 15181044.
  • Safdie FM, Dorff T, Quinn D, et al. Fasting and cancer treatment in humans: A case series report. Aging (Albany NY). 2009 Dec 31;1(12):988–1007. PubMed PMID: 20157582; PubMed Central PMCID: PMCPMC2815756.
  • Raffaghello L, Safdie F, Bianchi G, et al. Fasting and differential chemotherapy protection in patients. Cell Cycle. 2010 Nov 15;9(22):4474–4476. PubMed PMID: 21088487; PubMed Central PMCID: PMCPMC3048045.
  • Fontana L, Weiss EP, Villareal DT, et al. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans [Clinical Tria Comparative Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Aging Cell. 2008 Oct;7(5):681–687. PubMed PMID: 18843793; PubMed Central PMCID: PMC2673798. eng.
  • Harvie M, Howell A. Energy restriction and the prevention of breast cancer [Research Support, Non-U.S. Gov’t Review]. Proc Nutr Soc. 2012 May;71(2):263–275. PubMed PMID: 22414375; eng. .
  • Fairey AS, Courneya KS, Field CJ, et al. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. Cancer Epidemiology, Biomarkers & Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2003 Aug;12(8):721–727. PubMed PMID: 12917202; eng.
  • Allen NE, Appleby PN, Davey GK, et al. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans [Comparative Study Research Support, Non-U.S. Gov’t]. Cancer Epidemiology, Biomarkers & Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2002 Nov;11(11):1441–1448. PubMed PMID: 12433724; eng.
  • Lee C, Longo VD. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene. 2011 Jul 28;30(30):3305–3316. PubMed PMID: 21516129. .
  • Mantzoros C, Petridou E, Dessypris N, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab. 2004 Mar;89(3):1102–1107. PubMed PMID: 15001594.
  • Miyoshi Y, Funahashi T, Kihara S, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 2003 Nov 15;9(15):5699–5704. PubMed PMID: 14654554.
  • Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012 Aug;33(4):547–594. PubMed PMID: 22547160; PubMed Central PMCID: PMCPMC3410224. .
  • Newman G, Gonzalez-Perez RR. Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol. 2014 Jan 25;382(1):570–582. PubMed PMID: 23562747; PubMed Central PMCID: PMCPMC3844060. .
  • Rodriguez-Berriguete G, Sanchez-Espiridion B, Cansino JR, et al. Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-alpha signaling pathways in prostate cancer. Cytokine. 2013 Nov;64(2):555–563. PubMed PMID: 24063999; Eng.
  • Fontana L. Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction [Research Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov’t Review]. Exp Gerontol. 2009 Jan-Feb;44(1–2):41–45. PubMed PMID: 18502597; PubMed Central PMCID: PMC2652518. eng. .
  • Waters JP, Pober JS, Bradley JR. Tumour necrosis factor and cancer [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review]. J Pathol. 2013 Jul;230(3):241–248. PubMed PMID: 23460481; eng. .
  • Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma [Research Support, Non-U.S. Gov’t]. Anticancer Res. 1999 Mar-Apr;19(2B):1427–1432. PubMed PMID: 10365118; eng.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.